1. Home
  2. ARTL vs NCRA Comparison

ARTL vs NCRA Comparison

Compare ARTL & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARTL

Artelo Biosciences Inc.

N/A

Current Price

$3.98

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Logo Nocera Inc.

NCRA

Nocera Inc.

N/A

Current Price

$2.01

Market Cap

3.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
ARTL
NCRA
Founded
2011
2002
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.2M
3.1M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
ARTL
NCRA
Price
$3.98
$2.01
Analyst Decision
Hold
Analyst Count
2
0
Target Price
N/A
N/A
AVG Volume (30 Days)
138.0K
2.5M
Earning Date
05-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,627,944.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.52
$0.06
52 Week High
$19.91
$3.98

Technical Indicators

Market Signals
Indicator
ARTL
NCRA
Relative Strength Index (RSI) 68.14 48.45
Support Level $0.93 $1.72
Resistance Level $6.81 $2.59
Average True Range (ATR) 0.51 0.27
MACD 0.07 -0.02
Stochastic Oscillator 76.69 8.84

Price Performance

Historical Comparison
ARTL
NCRA

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

About NCRA Nocera Inc.

Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.

Share on Social Networks: